Fig. 9From: Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 casesVisual acuity at baseline and follow-up visits stratified by eyes that received treatment and eyes that were observed. The baseline VA is higher for treated patients compared to those who were not treated. There is no statistically significant difference in final visual acuity of treated eyes compared to those not treatedBack to article page